Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Dow
AstraZeneca
Baxter
Medtronic

Last Updated: May 17, 2022

CLINICAL TRIALS PROFILE FOR DEPAKOTE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Depakote

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00005015 ↗ Treatment of Depression in Youth With Bipolar Disorders Terminated National Institute of Mental Health (NIMH) Phase 3 1969-12-31 THIS STUDY HAS BEEN DISCONTINUED. The study is designed to evaluate the safety and efficacy of fluoxetine for treating children and adolescents with Bipolar Disorder who are experiencing an episode of major depression while being treated with a mood stabilizer. The study involves a 2-week assessment period. Patients who are on stable, therapeutic doses of lithium or valproate and continue to have depression will be randomized to a 12-week treatment of fluoxetine or placebo. Those who respond favorably to treatment will be followed openly for an 18-week continuation phase.
NCT00048802 ↗ Treatment and Outcome of Early Onset Bipolar Disorder Completed National Institute of Mental Health (NIMH) Phase 4 2002-08-01 This study will compare the effectiveness in the maintenance of continuing adjunctive atypical antipsychotic medication compared to traditional mood stabilizer(s) alone in the maintenance treatment of adolescents with bipolar disorder.
NCT00048802 ↗ Treatment and Outcome of Early Onset Bipolar Disorder Completed Northwell Health Phase 4 2002-08-01 This study will compare the effectiveness in the maintenance of continuing adjunctive atypical antipsychotic medication compared to traditional mood stabilizer(s) alone in the maintenance treatment of adolescents with bipolar disorder.
NCT00057681 ↗ Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents Completed National Institute of Mental Health (NIMH) Phase 3 2003-02-01 This study will evaluate the effectiveness of the medications, lithium (Eskalith®), valproate (Depakote®), and risperidone (Risperdal®) in treating children and adolescents with bipolar disorder or symptoms of mania.
NCT00057681 ↗ Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents Completed Washington University School of Medicine Phase 3 2003-02-01 This study will evaluate the effectiveness of the medications, lithium (Eskalith®), valproate (Depakote®), and risperidone (Risperdal®) in treating children and adolescents with bipolar disorder or symptoms of mania.
NCT00060905 ↗ An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder Completed Abbott Phase 3 2003-01-01 The purpose of this study is to determine the safety and effectiveness of Depakote ER compared to placebo in the treatment of bipolar disorder, manic or mixed type in adults.
NCT00063362 ↗ Combination Therapy for the Treatment of Bipolar Disorders Terminated National Institute of Mental Health (NIMH) Phase 3 2002-02-01 This study will compare triple and double drug regimens in the treatment of patients with depression, hypomania, or mania.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Depakote

Condition Name

Condition Name for Depakote
Intervention Trials
Bipolar Disorder 26
Healthy 16
Schizophrenia 4
Mania 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Depakote
Intervention Trials
Bipolar Disorder 32
Disease 24
Depression 5
Mood Disorders 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Depakote

Trials by Country

Trials by Country for Depakote
Location Trials
United States 205
India 8
Canada 3
Korea, Republic of 2
Egypt 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Depakote
Location Trials
Texas 17
Ohio 15
Illinois 13
California 13
New York 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Depakote

Clinical Trial Phase

Clinical Trial Phase for Depakote
Clinical Trial Phase Trials
Phase 4 29
Phase 3 18
Phase 2/Phase 3 1
[disabled in preview] 44
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Depakote
Clinical Trial Phase Trials
Completed 73
Terminated 10
Unknown status 5
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Depakote

Sponsor Name

Sponsor Name for Depakote
Sponsor Trials
Abbott 33
National Institute of Mental Health (NIMH) 10
Dr. Reddy's Laboratories Limited 7
[disabled in preview] 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Depakote
Sponsor Trials
Other 79
Industry 63
NIH 21
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
Mallinckrodt
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.